九源基因（02566）8月10日在港交所公告，董事会会议定于2026年8月19日（星期三）举行，拟审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其刊发事宜，同时审议中期股息建议（如有）。
公告显示，董事会目前由执行董事傅航先生、周伟先生，职工代表董事徐飞虎先生，非执行董事吴诗航先生、Albert Esteve Cruella先生、费俊杰先生、严瑋婷女士，以及独立非执行董事周智慧先生、何美仪女士、周德敏博士、黄文礼博士组成。
此次董事会的召开，将为市场提供公司2026年上半年经营表现及分红计划（如有）的最新信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.